country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

15 Results for "

CV-B3

" in MedChemExpress (MCE) Product Catalog:

Products (15)

Sort by :

Categories

By Targets

Products

Golgicide A

11 Publications Verification

Cat. No.: HY-100540

CAS No.: 1139889-93-2

Purity: 99.94%

Synonyms: GCA

Target:

Enterovirus

Research Areas:

Infection Cancer

Golgicide A (GCA) is a potent, highly specific, and reversible inhibitor of the cis-Golgi ADP-ribosylation factor guanine nucleotide exchange factors (ArfGEF) GBF1 . Golgicide A drastically reduced replication of coxsackievirus B3 (CVB3) and other human enterovirus species .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

TTP-8307

2 Cited Publications

Cat. No.: HY-124806

CAS No.: 950225-08-8

Purity: 99.90%

Target:

Enterovirus DNA/RNA Synthesis HCV

Research Areas:

Infection

TTP-8307 is a potent inhibitor of the replication of several rhino- and enteroviruses. TTP-8307 inhibits coxsackievirus B3 (CVB3; EC₅₀=1.2 μM) and poliovirus by interfering with the synthesis of viral RNA. TTP-8307 exerts antiviral activity through oxysterol-binding protein (OSBP) .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

cis-Resveratrol

1 Cited Publications

Cat. No.: HY-16561A

CAS No.: 61434-67-1

Category:

Infection Phenols Polyphenols Plants Other Families Extract Disease Research Fields

Target:

Enterovirus NF-κB

cis-Resveratrol exhibits signifcant antiviral activity. cis-Resveratrol inhibits enteroviruses with IC₅₀s of 12.2 µM and 37.6 µM for coxsackievirus B3 (CVB3) and enterovirus 71 (EV71), respectively. cis-Resveratrol is the inhibitor for NF-κB signaling pathway .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

MI 14

1 Cited Publications

Cat. No.: HY-110248

CAS No.: 1715934-43-2

Purity: 99.30%

Target:

PI4K HCV

Research Areas:

Infection

MI 14 is a selective PI4KIIIβ inhibitor with IC₅₀s of 54 nM, >100 μM, >100 μM for PI4KIIIβ, PI4KIIIα, PI4KIIα, respectively. MI 14 has antiviral activity against HCV 1b, CVB3, HRVM, HVC 2a .

Compare